Insider Transactions in Q1 2024 at Tarsus Pharmaceuticals, Inc. (TARS)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 18
2024
|
Bobak R. Azamian President/CEO and Board Chair |
SELL
Open market or private sale
|
Direct |
10,415
-28.25%
|
$312,450
$30.6 P/Share
|
|
Mar 18
2024
|
Bryan Wahl General Counsel |
SELL
Open market or private sale
|
Direct |
4,436
-9.77%
|
$133,080
$30.6 P/Share
|
|
Mar 18
2024
|
Aziz Mottiwala Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,766
-8.1%
|
$142,980
$30.6 P/Share
|
|
Mar 18
2024
|
Seshadri Neervannan Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
4,879
-7.01%
|
$146,370
$30.6 P/Share
|
|
Mar 18
2024
|
Dianne C. Whitfield Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
4,314
-11.21%
|
$129,420
$30.6 P/Share
|
|
Mar 15
2024
|
Bobak R. Azamian President/CEO and Board Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
28,274
+43.4%
|
-
|
|
Mar 15
2024
|
Bryan Wahl General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
12,038
+20.96%
|
-
|
|
Mar 15
2024
|
Aziz Mottiwala Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,938
+18.02%
|
-
|
|
Mar 15
2024
|
Seshadri Neervannan Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,245
+15.98%
|
-
|
|
Mar 15
2024
|
Dianne C. Whitfield Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,711
+23.33%
|
-
|